NOVABAY PHARMACEUTICALS INC (NBY)
US66987P3001 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -9.64M | -10.61M | -5.82M | -11.04M | -9.66M | |||
| Depreciation Amortization | 203.00K | 480.00K | 120.00K | 50.00K | 70.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 750.00K | 530.00K | -40.00K | 210.00K | 1.20M | |||
| Interest Paid | 326.00K | 20.00K | 0.00 | 50.00K | 150.00K | |||
| Taxes Paid | 359.00K | 20.00K | 20.00K | 10.00K | 10.00K | |||
| Other non cash items | 4.56M | 2.94M | -3.45M | 6.06M | 460.00K | |||
| OPERATING CASH FLOW | -4.13M | -6.65M | -9.19M | -4.72M | -7.93M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -19.00K | -110.00K | -50.00K | -30.00K | -20.00K | |||
| Other Investing Activity | N/A | 0.00 | -11.99M | N/A | N/A | |||
| INVESTING CASH FLOW | -19.00K | -110.00K | -12.05M | -30.00K | -20.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 1.34M | -110.00K | 110.00K | -2.56M | 2.35M | |||
| Stock Issued/Repurchased | 565.00K | 4.74M | 16.68M | 12.33M | 9.56M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | -200.00K | |||
| FINANCING CASH FLOW | 1.91M | 4.63M | 16.79M | 9.76M | 11.70M | |||
| CHANGE IN CASH | -2.24M | -2.13M | -4.45M | 5.01M | 3.75M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.13M | -6.65M | -9.19M | -4.72M | -7.93M | |||
| Capital Expenditure | -19.00K | -110.00K | -50.00K | -30.00K | -20.00K | |||
| FREE CASH FLOW | -4.15M | -6.76M | -9.24M | -4.75M | -7.95M | |||
All data in USD